Cargando…
T-705-Derived Prodrugs Show High Antiviral Efficacies against a Broad Range of Influenza A Viruses with Synergistic Effects When Combined with Oseltamivir
Emerging influenza A viruses (IAV) bear the potential to cause pandemics with unpredictable consequences for global human health. In particular, the WHO has declared avian H5 and H7 subtypes as high-risk candidates, and continuous surveillance of these viruses as well as the development of novel, br...
Autores principales: | Ganter, Benedikt, Zickler, Martin, Huchting, Johanna, Winkler, Matthias, Lüttjohann, Anna, Meier, Chris, Gabriel, Gülsah, Beck, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304372/ https://www.ncbi.nlm.nih.gov/pubmed/37376180 http://dx.doi.org/10.3390/pharmaceutics15061732 |
Ejemplares similares
-
Improving properties of the nucleobase analogs T-705/T-1105 as potential antiviral
por: Jia, Xiao, et al.
Publicado: (2021) -
Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever
por: Caroline, Amy L., et al.
Publicado: (2014) -
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
por: FURUTA, Yousuke, et al.
Publicado: (2017) -
Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections
por: Huchting, Johanna
Publicado: (2020) -
Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice
por: Marathe, Bindumadhav M., et al.
Publicado: (2016)